Label: NUTRALOX- calcium carbonate tablet, chewable

  • NDC Code(s): 50332-0151-1, 50332-0151-3, 50332-0151-4, 50332-0151-7, view more
    50332-0151-8
  • Packager: HART Health
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 9, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active Ingredient (in each tablet): Calcium Carbonate 420 mg

  • PURPOSE

    Purpose: Antacid

  • INDICATIONS & USAGE

    Uses: Temporarily relieves

    • heartburn
    • sour stomach
    • acid indigestion
    • upset stomach
  • WARNINGS

    Warnings:

  • ASK DOCTOR/PHARMACIST

    Ask a doctor or pharmacist before use if you are presently taking a prescription drug. Antacids may interfere with certain prescription drugs.

  • STOP USE

    Stop use and ask a doctor if symptoms last for more than 2 weeks

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222

  • DOSAGE & ADMINISTRATION

    Directions:

    Do not take more than directed

    Adults and children 12 years of age and over:

    • thoroughly chew 2 tablets every 3 to 4 hours as symptoms occur
    • do not take more than 16 tablets in 24 hours unless directed by a doctor
    • do not use the maximum dose for more than 2 weeks

    Children under 12 years of age: ask a doctor

  • OTHER SAFETY INFORMATION

    Other information:

    • Calcium content per tablet: 168mg
    • phenylketonurics: each tablet may contain 1.5 mg phenylalanine
    • tablets enclosed in a sealed packet
    • do not use if packet is torn, cut or open
    • store at 59° to 86°F (15°-30°C)
    • avoid excessive heat and humidity
  • INACTIVE INGREDIENT

    Inactive ingredients

    aspartame, croscarmellose sodium, magnesium stearate, maltodextrin, mint flavor, sorbitol

    May contain mineral oil

  • PRINCIPAL DISPLAY PANEL

    Nutralox.jpg

  • INGREDIENTS AND APPEARANCE
    NUTRALOX 
    calcium carbonate tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50332-0151
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CARBONATE420 mg
    Inactive Ingredients
    Ingredient NameStrength
    ASPARTAME (UNII: Z0H242BBR1)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    SORBITOL (UNII: 506T60A25R)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code AZ;036
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50332-0151-320 in 1 BOX, UNIT-DOSE01/20/1987
    12 in 1 PACKET; Type 0: Not a Combination Product
    2NDC:50332-0151-450 in 1 BOX, UNIT-DOSE01/20/1987
    22 in 1 PACKET; Type 0: Not a Combination Product
    3NDC:50332-0151-7125 in 1 BOX, UNIT-DOSE01/20/1987
    32 in 1 PACKET; Type 0: Not a Combination Product
    4NDC:50332-0151-8250 in 1 BOX, UNIT-DOSE01/20/1987
    42 in 1 PACKET; Type 0: Not a Combination Product
    5NDC:50332-0151-1500 in 1 BOX, UNIT-DOSE01/20/1987
    52 in 1 PACKET; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01/20/1987
    Labeler - HART Health (069560969)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!